The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Terry W. Moody

NCI Office of the Director

Center for Cancer Research

National Cancer Institute

31 Center Dr.

USA

[email]@mail.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • NCI Office of the Director, Center for Cancer Research, National Cancer Institute, 31 Center Dr., USA. 2002 - 2012
  • Department of Health and Human Services, National Cancer Institute, Center for Cancer Research, Office of the Director, USA. 2002 - 2010
  • Department of Health and Human Services, NCI Office of the Director, CCR, Bethesda, MD 20892 USA, USA. 2004 - 2008
  • NCI Office of the Director, CCR, Bethesda, MD 20892, USA. 2007
  • CCR, National Cancer Institute Office of the Director, National Institutes of Health, Department of Health and Human Services, USA. 2004

References

  1. PYK-2 is Tyrosine Phosphorylated after Activation of Pituitary Adenylate Cyclase Activating Polypeptide Receptors in Lung Cancer Cells. Moody, T.W., Di Florio, A., Jensen, R.T. J. Mol. Neurosci. (2012) [Pubmed]
  2. Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells. Moody, T.W., Osefo, N., Nuche-Berenguer, B., Ridnour, L., Wink, D., Jensen, R.T. J. Pharmacol. Exp. Ther. (2012) [Pubmed]
  3. Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin. Moody, T.W., Leyton, J., Jensen, R.T. J. Mol. Neurosci. (2012) [Pubmed]
  4. Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells. Moody, T.W., Berna, M.J., Mantey, S., Sancho, V., Ridnour, L., Wink, D.A., Chan, D., Giaccone, G., Jensen, R.T. Eur. J. Pharmacol. (2010) [Pubmed]
  5. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Moody, T.W., Switzer, C., Santana-Flores, W., Ridnour, L.A., Berna, M., Thill, M., Jensen, R.T., Sparatore, A., Del Soldato, P., Yeh, G.C., Roberts, D.D., Giaccone, G., Wink, D.A. Lung. Cancer (2010) [Pubmed]
  6. Bombesin marine toxin conjugates inhibit the growth of lung cancer cells. Moody, T.W., Pradhan, T., Mantey, S.A., Jensen, R.T., Dyba, M., Moody, D., Tarasova, N.I., Michejda, C.J. Life Sci. (2008) [Pubmed]
  7. Vasoactive intestinal peptide receptors: a molecular target in breast and lung cancer. Moody, T.W., Gozes, I. Curr. Pharm. Des. (2007) [Pubmed]
  8. Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells. Moody, T.W., Mantey, S.A., Fuselier, J.A., Coy, D.H., Jensen, R.T. Peptides (2007) [Pubmed]
  9. Thymosin alpha1 as a chemopreventive agent in lung and breast cancer. Moody, T.W. Ann. N. Y. Acad. Sci. (2007) [Pubmed]
  10. Peptide hormones and lung cancer. Moody, T.W. Panminerva. Med (2006) [Pubmed]
  11. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors. Moody, T.W., Sun, L.C., Mantey, S.A., Pradhan, T., Mackey, L.V., Gonzales, N., Fuselier, J.A., Coy, D.H., Jensen, R.T. J. Pharmacol. Exp. Ther. (2006) [Pubmed]
  12. Breast cancer VPAC1 receptors. Moody, T.W., Jensen, R.T. Ann. N. Y. Acad. Sci. (2006) [Pubmed]
  13. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells. Moody, T.W., Fuselier, J., Coy, D.H., Mantey, S., Pradhan, T., Nakagawa, T., Jensen, R.T. Peptides (2005) [Pubmed]
  14. VIP receptor antagonists inhibit mammary carcinogenesis in C3(1)SV40T antigen mice. Moody, T.W., Dudek, J., Zakowicz, H., Walters, J., Jensen, R.T., Petricoin, E., Couldrey, C., Green, J.E. Life Sci. (2004) [Pubmed]
  15. Bombesin-like peptides and associated receptors within the brain: distribution and behavioral implications. Moody, T.W., Merali, Z. Peptides (2004) [Pubmed]
  16. The development of VIP-ellipticine conjugates. Moody, T.W., Czerwinski, G., Tarasova, N.I., Moody, D.L., Michejda, C.J. Regul. Pept. (2004) [Pubmed]
  17. Neuropeptides as autocrine growth factors in cancer cells. Moody, T.W., Chan, D., Fahrenkrug, J., Jensen, R.T. Curr. Pharm. Des. (2003) [Pubmed]
  18. VIP as a trophic factor in the CNS and cancer cells. Moody, T.W., Hill, J.M., Jensen, R.T. Peptides (2003) [Pubmed]
  19. CAI inhibits the growth of small cell lung cancer cells. Moody, T.W., Chiles, J., Moody, E., Sieczkiewicz, G.J., Kohn, E.C. Lung. Cancer (2003) [Pubmed]
  20. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells. Moody, T.W., Leyton, J., Garcia-Marin, L., Jensen, R.T. Eur. J. Pharmacol. (2003) [Pubmed]
  21. VIP-ellipticine derivatives inhibit the growth of breast cancer cells. Moody, T.W., Czerwinski, G., Tarasova, N.I., Michejda, C.J. Life Sci. (2002) [Pubmed]
  22. PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Moody, T.W., Leyton, J., Casibang, M., Pisegna, J., Jensen, R.T. Regul. Pept. (2002) [Pubmed]
 
WikiGenes - Universities